- Home
- INTZ vs APM Comparison
INTZ vs APM Comparison
Compare INTZ & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- APM
- Stock Information
- Founded
- INTZ 1983
- APM 2010
- Country
- INTZ United States
- APM United Kingdom
- Employees
- INTZ N/A
- APM N/A
- Industry
- INTZ Computer Communications Equipment
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- APM Health Care
- Exchange
- INTZ Nasdaq
- APM Nasdaq
- Market Cap
- INTZ 4.9M
- APM 4.0M
- IPO Year
- INTZ 2020
- APM 2018
- Fundamental
- Price
- INTZ $0.46
- APM $0.72
- Analyst Decision
- INTZ Buy
- APM
- Analyst Count
- INTZ 2
- APM 0
- Target Price
- INTZ $6.00
- APM N/A
- AVG Volume (30 Days)
- INTZ 262.1K
- APM 69.7K
- Earning Date
- INTZ 11-12-2024
- APM 12-27-2024
- Dividend Yield
- INTZ N/A
- APM N/A
- EPS Growth
- INTZ N/A
- APM N/A
- EPS
- INTZ N/A
- APM N/A
- Revenue
- INTZ $5,461,000.00
- APM $431,378.00
- Revenue This Year
- INTZ $9.53
- APM $157,729.10
- Revenue Next Year
- INTZ $49.46
- APM N/A
- P/E Ratio
- INTZ N/A
- APM N/A
- Revenue Growth
- INTZ N/A
- APM N/A
- 52 Week Low
- INTZ $0.43
- APM $0.46
- 52 Week High
- INTZ $5.40
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- INTZ 28.40
- APM 41.12
- Support Level
- INTZ $0.43
- APM $0.73
- Resistance Level
- INTZ $0.63
- APM $0.78
- Average True Range (ATR)
- INTZ 0.04
- APM 0.09
- MACD
- INTZ -0.01
- APM 0.04
- Stochastic Oscillator
- INTZ 14.95
- APM 64.47
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. It is engaged in developing, marketing, and supporting a group of entity identification, high-speed data mining, cybercrime, and persistent threat detection products. The company's product consists of TraceCop which is for identity discovery and disclosure, Savant for network data mining and persistent threat detection, and Compliance Commander which is for regulated information and data privacy protection. In addition, its products are used by various customers including banks, credit unions, other financial institutions, United States federal government entities, foreign government entities, hospitals, and other healthcare providers.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.